Merit Medical Financials

MM3 Stock

EUR 69.00 1.00 1.47%

Financial data analysis helps to check out if markets are presently mispricing Merit Medical Systems. We were able to interpolate thirty-three available fundamentals for Merit Medical, which can be compared to its peers in the industry. The stock experiences a large bullish trend. Check odds of Merit Medical to be traded at €75.9 in 90 days.

Covid

Interest Hikes

Merit Medical Balance Sheet Chart

At this time, Merit Medical's Cash is most likely to increase significantly in the upcoming years. The Merit Medical's current Long Term Debt is estimated to increase to about 880.9 M, while Other Current Liabilities is projected to decrease to roughly 20.9 M.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Key indicators impacting Merit Medical's financial strength include:

Current Value

Last Year

Change From Last Year

10 Year Trend

Operating Income

188.5 M

179.6 M

Sufficiently Up

Slightly volatile

Merit Medical Stock Summary

Merit Medical competes with Cerence, TELES Informationstech, BIOTIME, MBIA, and MBIA. Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Merit Medical Systems, Inc. was founded in 1987 and is headquartered in South Jordan, Utah. MERIT MED operates under Medical Instruments Supplies classification in Germany and is traded on Frankfurt Stock Exchange. It employs 6300 people.

Specialization	Health Care, Health Care Equipment & Services
Instrument	Germany Stock View All
Exchange	Frankfurt Exchange
ISIN	US5898891040
Business Address	1600 West Merit
Sector	Health Care Equipment & Supplies
Industry	Health Care
Benchmark	Dow Jones Industrial
Website	www.merit.com
Phone	801 253 1600
Currency	EUR - Euro

You should never invest in Merit Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Merit Stock, because this is throwing your money away. Analyzing the key information contained in Merit Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Merit Medical Key Financial Ratios

There are many critical financial ratios that Merit Medical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Merit Medical Systems reports annually and quarterly.

	Revenue	1.36 B
	Gross Profit	715.9 M
	EBITDA	291.78 M
	Net Income	120.36 M
	Total Asset	2.42 B

More Fundamentals

Merit Medical Key Balance Sheet Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Total Assets	1.6B	1.7B	2.3B	2.4B	2.8B	1.7B
Other Current Liab	31.7M	21.9M	55.7M	23.7M	27.2M	20.9M
Other Liab	120.7M	102.7M	74.8M	52.4M	60.3M	78.4M
Net Tangible Assets	151.4M	227.1M	358.8M	508.7M	585.0M	614.3M
Retained Earnings	406.3M	480.8M	575.2M	695.5M	799.9M	438.6M
Accounts Payable	55.6M	68.5M	65.9M	68.5M	78.8M	55.0M
Cash	67.8M	58.4M	587.0M	376.7M	433.2M	454.9M
Other Assets	26.9M	30.2M	32.8M	31.9M	36.7M	29.0M
Long Term Debt	234.4M	186.8M	823.0M	729.6M	839.0M	880.9M
Net Receivables	152.3M	164.7M	177.9M	190.2M	218.8M	151.0M
Good Will	361.7M	359.8M	382.2M	463.5M	533.0M	343.8M
Inventory	221.9M	266.0M	303.9M	306.1M	352.0M	219.3M
Other Current Assets	5.6M	10.8M	24.3M	28.5M	32.8M	34.5M
Total Liab	608.5M	519.6M	1.1B	1.0B	1.2B	699.6M
Total Current Assets	482.2M	529.1M	1.1B	923.8M	1.1B	531.4M
Intangible Assets	319.3M	275.9M	325.9M	498.3M	573.0M	332.5M
Common Stock	587.0M	606.2M	641.5M	675.2M	776.5M	492.1M
Net Debt	175.1M	139.6M	236.0M	352.8M	317.6M	216.7M
Net Invested Capital	1.3B	1.3B	2.0B	2.1B	2.4B	1.6B
Net Working Capital	245.9M	308.4M	904.9M	707.4M	813.5M	431.6M
Capital Stock	641.5M	675.2M	638.2M	703.2M	808.7M	695.0M

Merit Medical Key Income Statement Accounts

An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.

	2021	2022	2023	2024	2025	2026 (projected)
Interest Expense	5.3M	6.3M	15.5M	31.2M	35.9M	37.7M
Total Revenue	1.1B	1.2B	1.3B	1.4B	1.6B	1.0B
Gross Profit	485.3M	519.1M	583.9M	643.3M	739.8M	451.2M
Operating Income	78.4M	94.4M	127.5M	156.1M	179.6M	188.5M
Ebit	43.0M	45.9M	103.0M	102.1M	117.4M	72.0M
Research Development	71.2M	82.2M	82.7M	87.5M	100.6M	68.0M
Cost Of Revenue	589.4M	631.9M	673.5M	713.2M	820.2M	555.2M
Income Before Tax	53.9M	82.6M	112.1M	150.0M	172.5M	181.1M
Net Income	48.5M	74.5M	94.4M	120.4M	138.4M	145.3M
Income Tax Expense	(3.3M)	(3.4M)	5.5M	8.1M	7.3M	3.9M
Tax Provision	5.5M	8.1M	17.7M	29.6M	34.1M	35.8M
Net Interest Income	(4.5M)	(5.9M)	(13.1M)	(5.0M)	(5.7M)	(6.0M)
Interest Income	769K	439K	2.5M	26.2M	30.2M	31.7M
Ebitda	119.3M	103.6M	155.0M	181.2M	208.3M	144.0M

Merit Medical Key Cash Accounts

Cash flow analysis captures how much money flows into and out of Merit Medical Systems. It measures of how well Merit is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Merit Medical brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Merit had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Merit Medical has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (capital allocation) and investing in non-business activities like paying off debt or making acquisitions.

	2021	2022	2023	2024	2025	2026 (projected)
Change To Inventory	(25.2M)	(47.9M)	(32.1M)	(2.3M)	(2.1M)	(2.2M)
Investments	(37.2M)	(57.4M)	(175.3M)	(368.7M)	(331.8M)	(315.2M)
Change In Cash	10.8M	(7.2M)	528.6M	(210.4M)	(241.9M)	(229.8M)
Net Borrowings	(108.5M)	(44.9M)	619.6M	(99.1M)	(113.9M)	(108.2M)
Depreciation	95.8M	92.2M	101.3M	114.7M	131.9M	85.5M
Capital Expenditures	27.9M	45.0M	36.7M	38.0M	34.2M	35.9M
Net Income	48.5M	74.5M	94.4M	120.4M	138.4M	145.3M
Change To Netincome	22.8M	33.5M	20.2M	18.4M	21.1M	15.0M
End Period Cash Flow	67.8M	60.6M	589.1M	378.8M	435.6M	457.4M
Free Cash Flow	119.3M	69.3M	108.5M	182.8M	210.2M	220.7M
Other Non Cash Items	5.0M	12.2M	4.9M	7.1M	8.2M	5.1M

Merit Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Merit Medical's current stock value. Our valuation model uses many indicators to compare Merit Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Merit Medical competition to find correlations between indicators driving Merit Medical's intrinsic value. More Info.

Merit Medical Systems is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.52 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Merit Medical Systems is roughly 1.94 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Merit Medical's earnings, one of the primary drivers of an investment's value.

Merit Medical Systems Total Assets Over Time

Most indicators from Merit Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Merit Medical Systems current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

At this time, Merit Medical's Tax Provision is most likely to increase significantly in the upcoming years. The Merit Medical's current Issuance Of Capital Stock is estimated to increase to about 37.2 M, while Selling General Administrative is projected to decrease to roughly 307 M.

	2023	2024	2025	2026 (projected)
Gross Profit	583.9M	643.3M	739.8M	451.2M
Total Revenue	1.3B	1.4B	1.6B	1.0B

Gross Profit Total Revenue

Merit Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Good Will	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Non Current Assets Total
Total Assets		0.72	0.92	0.99	0.51	0.79	0.95	0.96	0.79	0.86	0.81	0.98	0.98	0.99	0.68	-0.78	0.98	0.8	0.91	0.01	0.95	-0.19	0.92	0.94	0.93	0.97
Other Current Liab	0.72		0.89	0.75	0.67	0.52	0.56	0.75	0.37	0.76	0.37	0.77	0.76	0.73	0.21	-0.6	0.64	0.69	0.76	-0.08	0.57	-0.18	0.74	0.84	0.81	0.76
Total Current Liabilities	0.92	0.89		0.96	0.6	0.78	0.83	0.96	0.62	0.91	0.61	0.96	0.95	0.95	0.49	-0.79	0.84	0.83	0.89	-0.01	0.82	-0.19	0.88	0.99	0.96	0.93
Total Stockholder Equity	0.99	0.75	0.96		0.51	0.83	0.95	0.98	0.73	0.89	0.73	0.99	0.99	0.99	0.64	-0.8	0.93	0.81	0.91	0.02	0.92	-0.19	0.91	0.97	0.94	0.97
Other Liab	0.51	0.67	0.6	0.51		0.13	0.25	0.49	0.15	0.67	0.29	0.59	0.55	0.48	-0.01	-0.14	0.49	0.68	0.73	0.31	0.29	0.34	0.74	0.64	0.59	0.61
Net Tangible Assets	0.79	0.52	0.78	0.83	0.13		0.85	0.84	0.85	0.67	0.77	0.78	0.78	0.84	0.84	-0.89	0.72	0.53	0.62	-0.12	0.82	-0.22	0.59	0.74	0.74	0.75
Retained Earnings	0.95	0.56	0.83	0.95	0.25	0.85		0.92	0.81	0.76	0.8	0.91	0.93	0.95	0.78	-0.8	0.91	0.69	0.81	-0.01	0.95	-0.24	0.82	0.84	0.82	0.89
Accounts Payable	0.96	0.75	0.96	0.98	0.49	0.84	0.92		0.72	0.84	0.7	0.97	0.96	0.98	0.63	-0.86	0.89	0.76	0.9	0.0	0.9	-0.21	0.87	0.96	0.93	0.94
Cash	0.79	0.37	0.62	0.73	0.15	0.85	0.81	0.72		0.57	0.96	0.71	0.71	0.77	0.91	-0.75	0.83	0.47	0.62	-0.05	0.89	-0.13	0.59	0.62	0.62	0.7
Other Assets	0.86	0.76	0.91	0.89	0.67	0.67	0.76	0.84	0.57		0.59	0.9	0.88	0.88	0.42	-0.55	0.79	0.94	0.88	0.28	0.76	0.11	0.86	0.92	0.85	0.84
Long Term Debt	0.81	0.37	0.61	0.73	0.29	0.77	0.8	0.7	0.96	0.59		0.74	0.74	0.76	0.91	-0.67	0.86	0.52	0.67	-0.05	0.84	-0.05	0.7	0.62	0.64	0.76
Net Receivables	0.98	0.77	0.96	0.99	0.59	0.78	0.91	0.97	0.71	0.9	0.74		0.99	0.98	0.6	-0.76	0.93	0.82	0.93	0.04	0.9	-0.15	0.94	0.98	0.95	0.98
Good Will	0.98	0.76	0.95	0.99	0.55	0.78	0.93	0.96	0.71	0.88	0.74	0.99		0.97	0.63	-0.77	0.93	0.81	0.91	-0.02	0.9	-0.2	0.94	0.96	0.95	0.99
Inventory	0.99	0.73	0.95	0.99	0.48	0.84	0.95	0.98	0.77	0.88	0.76	0.98	0.97		0.66	-0.82	0.94	0.81	0.89	0.02	0.94	-0.21	0.89	0.96	0.94	0.94
Other Current Assets	0.68	0.21	0.49	0.64	-0.01	0.84	0.78	0.63	0.91	0.42	0.91	0.6	0.63	0.66		-0.73	0.69	0.35	0.49	-0.16	0.75	-0.16	0.51	0.47	0.5	0.63
Other Stockholder Equity	-0.78	-0.6	-0.79	-0.8	-0.14	-0.89	-0.8	-0.86	-0.75	-0.55	-0.67	-0.76	-0.77	-0.82	-0.73		-0.72	-0.47	-0.61	0.35	-0.8	0.51	-0.57	-0.75	-0.79	-0.74
Total Liab	0.98	0.64	0.84	0.93	0.49	0.72	0.91	0.89	0.83	0.79	0.86	0.93	0.93	0.94	0.69	-0.72		0.75	0.87	-0.01	0.96	-0.19	0.9	0.87	0.87	0.93
Deferred Long Term Liab	0.8	0.69	0.83	0.81	0.68	0.53	0.69	0.76	0.47	0.94	0.52	0.82	0.81	0.81	0.35	-0.47	0.75		0.81	0.21	0.68	0.05	0.83	0.84	0.82	0.77
Long Term Investments	0.91	0.76	0.89	0.91	0.73	0.62	0.81	0.9	0.62	0.88	0.67	0.93	0.91	0.89	0.49	-0.61	0.87	0.81		0.28	0.8	0.1	0.95	0.92	0.82	0.92
Short Long Term Debt	0.01	-0.08	-0.01	0.02	0.31	-0.12	-0.01	0.0	-0.05	0.28	-0.05	0.04	-0.02	0.02	-0.16	0.35	-0.01	0.21	0.28		0.0	0.88	0.15	0.05	-0.19	-0.03
Total Current Assets	0.95	0.57	0.82	0.92	0.29	0.82	0.95	0.9	0.89	0.76	0.84	0.9	0.9	0.94	0.75	-0.8	0.96	0.68	0.8	0.0		-0.24	0.78	0.84	0.82	0.86
Short Term Debt	-0.19	-0.18	-0.19	-0.19	0.34	-0.22	-0.24	-0.21	-0.13	0.11	-0.05	-0.15	-0.2	-0.21	-0.16	0.51	-0.19	0.05	0.1	0.88	-0.24		0.02	-0.16	-0.34	-0.16
Intangible Assets	0.92	0.74	0.88	0.91	0.74	0.59	0.82	0.87	0.59	0.86	0.7	0.94	0.94	0.89	0.51	-0.57	0.9	0.83	0.95	0.15	0.78	0.02		0.9	0.87	0.96
Common Stock	0.94	0.84	0.99	0.97	0.64	0.74	0.84	0.96	0.62	0.92	0.62	0.98	0.96	0.96	0.47	-0.75	0.87	0.84	0.92	0.05	0.84	-0.16	0.9		0.96	0.94
Property Plant Equipment	0.93	0.81	0.96	0.94	0.59	0.74	0.82	0.93	0.62	0.85	0.64	0.95	0.95	0.94	0.5	-0.79	0.87	0.82	0.82	-0.19	0.82	-0.34	0.87	0.96		0.93
Non Current Assets Total	0.97	0.76	0.93	0.97	0.61	0.75	0.89	0.94	0.7	0.84	0.76	0.98	0.99	0.94	0.63	-0.74	0.93	0.77	0.92	-0.03	0.86	-0.16	0.96	0.94	0.93

Click cells to compare fundamentals

Merit Medical Account Relationship Matchups

Merit Medical fundamental ratios Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Total Assets	1.6B	1.7B	2.3B	2.4B	2.8B	1.7B
Other Current Liab	31.7M	21.9M	55.7M	23.7M	27.2M	20.9M
Other Liab	120.7M	102.7M	74.8M	52.4M	60.3M	78.4M
Net Tangible Assets	151.4M	227.1M	358.8M	508.7M	585.0M	614.3M
Retained Earnings	406.3M	480.8M	575.2M	695.5M	799.9M	438.6M
Accounts Payable	55.6M	68.5M	65.9M	68.5M	78.8M	55.0M
Cash	67.8M	58.4M	587.0M	376.7M	433.2M	454.9M
Other Assets	26.9M	30.2M	32.8M	31.9M	36.7M	29.0M
Long Term Debt	234.4M	186.8M	823.0M	729.6M	839.0M	880.9M
Net Receivables	152.3M	164.7M	177.9M	190.2M	218.8M	151.0M
Good Will	361.7M	359.8M	382.2M	463.5M	533.0M	343.8M
Inventory	221.9M	266.0M	303.9M	306.1M	352.0M	219.3M
Other Current Assets	5.6M	10.8M	24.3M	28.5M	32.8M	34.5M
Total Liab	608.5M	519.6M	1.1B	1.0B	1.2B	699.6M
Total Current Assets	482.2M	529.1M	1.1B	923.8M	1.1B	531.4M
Intangible Assets	319.3M	275.9M	325.9M	498.3M	573.0M	332.5M
Common Stock	587.0M	606.2M	641.5M	675.2M	776.5M	492.1M
Net Debt	175.1M	139.6M	236.0M	352.8M	317.6M	216.7M
Net Invested Capital	1.3B	1.3B	2.0B	2.1B	2.4B	1.6B
Net Working Capital	245.9M	308.4M	904.9M	707.4M	813.5M	431.6M
Capital Stock	641.5M	675.2M	638.2M	703.2M	808.7M	695.0M

Merit Medical February 18, 2026 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Merit Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Merit Medical Systems. We use our internally-developed statistical techniques to arrive at the intrinsic value of Merit Medical Systems based on widely used predictive technical indicators. In general, we focus on analyzing Merit Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Merit Medical's daily price indicators and compare them against related drivers.

	Information Ratio	(0.08)
	Maximum Drawdown	14.21
	Value At Risk	(2.88)
	Potential Upside	2.96

Complementary Tools for Merit Stock analysis

When running Merit Medical's price analysis, check to measure Merit Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merit Medical is operating at the current time. Most of Merit Medical's value examination focuses on studying past and present price action to predict the probability of Merit Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merit Medical's price. Additionally, you may evaluate how the addition of Merit Medical to your portfolios can decrease your overall portfolio volatility.

	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Stocks Directory Find actively traded stocks across global markets
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC